Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. | PeerJ | 2021 | 33777535 | PubTator, text mining | PubMed |
| Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway. | Eur J Cancer | 2021 | 33770575 | PubTator, text mining | PubMed |
| Non-canonical role of wild-type SEC23B in the cellular stress response pathway. | Cell Death Dis | 2021 | 33753724 | PubTator, text mining | PubMed |
| Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer. | BMC Cancer | 2021 | 33750326 | PubTator, text mining | PubMed |
| CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic Metabolism. | Front Cell Dev Biol | 2021 | 33748130 | PubTator, text mining | PubMed |
| A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications. | Front Cell Dev Biol | 2021 | 33748108 | PubTator, text mining | PubMed |
| Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress. | Mol Cell | 2021 | 33743195 | PubTator, text mining | PubMed |
| Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1. | NPJ Precis Oncol | 2021 | 33742100 | PubTator, text mining | PubMed |
| Expression and prognosis analysis of GINS subunits in human breast cancer. | Medicine (Baltimore) | 2021 | 33725952 | PubTator, text mining | PubMed |
| Integrated Protein-Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma. | Front Cell Dev Biol | 2021 | 33718368 | PubTator, text mining | PubMed |
| Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. | Nat Commun | 2021 | 33712570 | PubTator, text mining | PubMed |
| Functional differences and similarities in activated peripheral blood mononuclear cells by lipopolysaccharide or phytohemagglutinin stimulation between human and cynomolgus monkeys. | Ann Transl Med | 2021 | 33708884 | PubTator, text mining | PubMed |
| Gene alteration in zebrafish exposed to a mixture of substances of abuse. | Environ Pollut | 2021 | 33689951 | PubTator, text mining | PubMed |
| Human ORC/MCM density is low in active genes and correlates with replication time but does not delimit initiation zones. | Elife | 2021 | 33683199 | PubTator, text mining | PubMed |
| Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma. | Front Immunol | 2021 | 33679756 | PubTator, text mining | PubMed |
| PRMT5 promotes colorectal cancer growth by interaction with MCM7. | J Cell Mol Med | 2021 | 33675123 | PubTator, text mining | PubMed |
| Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers. | Oncogene | 2021 | 33674744 | PubTator, text mining | PubMed |
| Is Inflammation a Friend or Foe for Orthodontic Treatment?: Inflammation in Orthodontically Induced Inflammatory Root Resorption and Accelerating Tooth Movement. | Int J Mol Sci | 2021 | 33673606 | PubTator, text mining | PubMed |
| Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas. | J Pers Med | 2021 | 33672271 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Caco-2 Cells upon the Exposure of Mycotoxin Deoxynivalenol and Its Acetylated Derivatives. | Toxins (Basel) | 2021 | 33671637 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=40